
Werewolf Therapeutics Inc (HOWL)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -168.172 | -47.794 | -146.509 | -31.7 | -22.304 |
Return on Equity (%) | 150.008 | 74.092 | -400.153 | -39.117 | -31.978 |
Return on Invested Capital (%) | -207.844 | -45.528 | -41.776 | -41.42 | -33.452 |
Operating Margin (%) | N/A | N/A | N/A | -328.09 | -171.634 |
Net Profit Margin (%) | N/A | N/A | N/A | -328.09 | -187.374 |
Book Value Per Share | 0.649 | 5.894 | 5.594 | 3.892 | 3.077 |
Earnings Per Share | -1.211 | -1.864 | -7.393 | -1.712 | -1.032 |
Cash Per Share | 1.189 | 6.115 | 5.768 | 4.114 | 3.712 |
Working Capital Per Share | 1.064 | 5.789 | 5.462 | 3.697 | 3.288 |
Operating Profit Per Share | N/A | N/A | N/A | 0.522 | 0.551 |
EBIT Per Share | -0.681 | -0.994 | -1.83 | -1.712 | -1.032 |
EBITDA Per Share | -0.681 | -0.994 | -1.83 | -1.712 | -1.032 |
Free Cash Flow Per Share | -1.195 | -1.837 | -7.383 | -1.632 | -1.06 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 15,06M | 15,14M | 27,31M | 31,43M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 31,43M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -268.414 | N/A | N/A | N/A | -2047.17 | N/A | N/A |
Net Profit Margin (%) | N/A | -268.414 | N/A | N/A | N/A | -2182.345 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 61,5M |
Ratio cours/bénéfice | -1,6 |
Ratio prix/ventes | 2,99 |
Ratio prix/liquidités | 0,44 |
Ratio prix/valeur comptable | 0,54 |
Rendement de dividende | - |
Actions en circulation | 44,56M |
Volume moyen (1 semaine) | 160,67k |
Volume moyen (1 mois) | 251,3k |
Variation sur 52 semaines | -82,46% |
Plus haut sur 52 semaines | 8,1939 |
Plus bas sur 52 semaines | 1,26 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales